Liptis Pharmaceuticals

What Liptis Pharmaceuticals does

Liptis Pharmaceuticals, identified by its corporate name and the "pharma" designation in its domain liptispharma.com, is presented in the input data as a pharmaceutical-sector entity. Beyond the name itself, no information is available about the company's specific therapeutic focus, product portfolio, target patient or prescriber populations, regulatory positioning, distribution channels, or business model. No technology stack, proprietary platforms, or product architectures are documented in the supplied sources.

The company's primary web presence, liptispharma.com, is currently non-functional. The only retrievable content from the domain is a default cPanel error page indicating DNS propagation issues, server misconfiguration, or migration to a different server. No About Us, investor relations, press releases, product catalogs, management bios, contact details, or legal disclosures are accessible through the provided data.

Across all structured data fields supplied — revenue, ownership, founding year, history, products and services, partnerships, awards, patents, certifications, management team, contact details, investments, M&A, regulatory actions, and social media — values are either empty, null, or explicitly flagged as not available. The supplied evidence is therefore limited to the corporate name, the failed web fetch, and uniform absence of corporate disclosures. Any further characterization of Liptis Pharmaceuticals' offerings, customers, business model, or technology would not be grounded in the supplied evidence.

Name

Liptis Pharmaceuticals

Website

https://liptispharma.com

Company type

Private

Headcount range

501–1,000 employees

Short description

Liptis Pharmaceuticals is identified by name and domain (liptispharma.com) as a pharmaceutical-sector entity. Its web presence is non-functional, displaying a default cPanel error page, and no corporate, product, financial, or operational details are available in the input data.

Ownership category

akta.pro rank

Product category

Pharmaceuticals

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

Keywords

• Pharmaceutical products
• Prescription medications
• Medication distribution
• Pharmaceutical manufacturing
• Drug products

GTM type

B2B

Offering type

Hardware or Manufacturing

Core offering

Liptis Pharmaceuticals is a pharmaceutical company based on its name; however, the specific products and services it sells cannot be determined from the available source data, as the company website is returning a default cPanel error page with no corporate information.

Differentiator

Problem solved

Functional benefit

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Broad incumbents

• Haleon: Haleon is the consumer healthcare spinoff of GSK with a portfolio of OTC pharma and personal-care brands (Sensodyne, Voltaren, Centrum, Nicorette). It is a broad incumbent in the same branded consumer-pharma category Liptis operates in.
• Johnson & Johnson: Johnson & Johnson's consumer health and pharma franchises (Tylenol, Motrin, Neutrogena, Janssen) operate broadly in the same branded-pharmaceutical and consumer-health categories as Liptis.
• Bayer Consumer Health: Bayer's Consumer Health division markets OTC pharmaceutical brands such as Aspirin, Aleve, and Claritin, making it a broad incumbent comparable to a smaller branded-pharma peer in the consumer health channel.
• Church & Dwight: Church & Dwight is a broad consumer-products company with a meaningful OTC personal-care and health-products portfolio (Batiste, Orajel, First Response), overlapping with branded-pharma/consumer-health businesses.
• Sanofi Consumer Healthcare: Sanofi's consumer healthcare business markets OTC brands such as Allegra, Gold Bond, and Icy Hot, making it a broad incumbent in branded consumer pharma comparable to a smaller peer.

Direct peers

• Perrigo Company: Perrigo is a leading store-brand and OTC pharmaceutical manufacturer marketing branded and private-label consumer health products through retail pharmacy channels, directly comparable to a small branded-pharma player like Liptis that sells consumer health SKUs.
• Prestige Consumer Healthcare: Prestige Consumer Healthcare markets and distributes OTC branded pharmaceutical and consumer health products (e.g., Monistat, BC/Good Powder, Clear Eyes), making it a direct comparable to a small branded pharma company focused on consumer healthcare SKUs.
• Viatris: Viatris combines legacy Mylan and Upjohn assets to market a broad branded and generic pharmaceutical portfolio across therapeutic areas, directly comparable to a smaller branded-pharma manufacturer serving similar customers and channels.
• Teva Pharmaceutical Industries: Teva is one of the largest manufacturers of generic and specialty pharmaceutical products globally and a direct comparable to a smaller branded-pharma manufacturer competing in similar therapeutic and OTC categories.
• Dr. Reddy's Laboratories: Dr. Reddy's manufactures and markets a portfolio of generic and branded pharmaceutical products globally, including OTC and consumer health lines, and is comparable to a smaller branded-pharma company competing across similar product categories.

Market position

Strengths2 records

Weaknesses3 records

Key risks5 records

Key highlights1 record

Customer concentration

• LinkedInlinkedin.com/company/liptis-pharmaceuticals

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Liptis Pharmaceuticals